Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - OtherShares OutstandingShares Outstanding
Ratios

Janux Therapeutics (JANX) Receivables - Accured (2021 - 2025)

Janux Therapeutics has reported Receivables - Accured over the past 5 years, most recently at $6.4 million for Q4 2025.

  • Quarterly Receivables - Accured rose 18.52% to $6.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, up 18.52% year-over-year, with the annual reading at $6.4 million for FY2025, 18.52% up from the prior year.
  • Receivables - Accured was $6.4 million for Q4 2025 at Janux Therapeutics, up from $6.3 million in the prior quarter.
  • Over five years, Receivables - Accured peaked at $28.0 million in Q3 2021 and troughed at $3000.0 in Q2 2021.
  • The 5-year median for Receivables - Accured is $2.2 million (2023), against an average of $4.1 million.
  • The largest YoY upside for Receivables - Accured was 9900.0% in 2022 against a maximum downside of 98.93% in 2022.
  • A 5-year view of Receivables - Accured shows it stood at $200000.0 in 2021, then soared by 250.0% to $700000.0 in 2022, then surged by 214.29% to $2.2 million in 2023, then surged by 145.45% to $5.4 million in 2024, then increased by 18.52% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for JANX's Receivables - Accured are $6.4 million (Q4 2025), $6.3 million (Q3 2025), and $5.7 million (Q2 2025).